Toggle navigation
About Us
Portfolio
News
Contact Us
Lightchain Capital
Recent News
August 08, 2023
AI Proteins Strengthens Leadership with Appointment of Noah D. Beerman as Chief Executive Officer and Industry Leader Mark J. Alles as Chairman of the Board of Directors
READ MORE
August 03, 2023
Closing the Gap: Why Healthcare Needs More Gender Diversity in Leadership
READ MORE
July 20, 2023
Startup Exit Awards 2023: Supercomputer startup SimpleRose raises $23M to bring its technology to market
READ MORE
July 17, 2023
C4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
READ MORE
July 10, 2023
Q&A with Rory Johnson, PhD
READ MORE
July 05, 2023
C4 Therapeutics Announces FDA Clearance of Investigational New Drug Application for CFT8919, an Orally Bioavailable BiDAC™ Degrader Targeting EGFR L858R for Non-Small Cell Lung Cancer
READ MORE
June 21, 2023
Small box. Big ambitions
READ MORE
June 21, 2023
Q&A with Susan Carpenter, PhD
READ MORE
June 20, 2023
C4 Therapeutics Appoints Leonard Reyno, M.D., as Chief Medical Officer
READ MORE
1
5
6
7
8
9
10
11
...
29
Contact Us
Lightchain Capital, LLC
PO Box 31729
St. Louis, MO 63131
Submit
4837,4748,4815,4823,4811,4819,4822,4748,4772,4748,4789,4811,4830,4819,4815,4760,4792,4760,4791,4825,4828,4817,4811,4824,4778,4825,4831,4830,4822,4825,4825,4821,4760,4813,4825,4823,4748,4758,4748,4829,4831,4812,4820,4815,4813,4830,4748,4772,4748,4781,4825,4824,4830,4811,4813,4830,4746,4784,4825,4828,4823,4748,4839
©2024 LIGHTCHAIN CAPITAL, LLC All Rights Reserved |
Privacy Policy
Website by
Tidal Media Group